That's why you invest in biotech stock for bagger return isn't it??? No doubt once RAP realise their revenue potential for multiple products with massive market the market will rerate RAP's MC accordingly.
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%